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Research institutions invest substantial 
resources to achieve innovative results. 
Intellectual property (IP) protection is essential 
in this process so that such institutions can 
reap the benefits of their research activities 
and continue innovating. 
This new bulletin issue focuses on the 
importance and the role played by IP in the 
context of research activities and how IP is 
managed by research institutions. 
Firstly, WIPO introduces us to institutional 
intellectual property policies and explains 
how WIPO can assist on this matter. 
OpenAIRE talks about open access and the 
different ways to make research results freely 
available under this practice. 
Dr Dragan Indjin a COST Action Chair and 
Grant Holder shares with us his success story 
and his experience in research and IP. 
Dr Claudia Tapia from 4iPCouncil explains 
how to collaborate in research projects while 
keeping IP business protected. 
The European champion, TECNALIA, which 
has recently received the European Innovation 
Award, describes to us its experience in 
IP management in the context of research 
projects.
An article by the Luxembourg National 
Research Fund (FNR) summarises the 
initiatives and programmes which it provides 
for research projects.
As a closure to these articles and interviews, 
Professor Jennifer Littlechild, coordinator of 
the ERA-net project THERMOGENE, tells us in 
an interview about her experience in research 
projects and the importance of IP and IP 
management for their success. 
As per usual, the Bulletin reports information 
about the European IPR Helpdesk’s past and 
future events together with the latest updates 
from our Helpline service.
This time, you will also find a short article 
regarding the Autumn Meeting for the 
European IPR Helpdesk Ambassadors that 
was held in Brussels.
Finally, we invite you to test your knowledge 
on patent searching with our usual patent 
quiz and try to solve our brand-new IP and 
research multiple choice test.
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economic benefits arising from the 
commercialisation of IP; and,
• rules regarding conflicts of interest and 
the establishment of policy safeguards. 
Why are IP policies important for 
academic institutions?
Establishing an IP policy is necessary for 
several important reasons:
• it protects and increases the value of 
research and innovation generated by 
faculty and students; 
• it can significantly increase the 
institution’s attractiveness to industry, 
by ensuring a predictable, stable 
environment of IP protection and 
commercialisation; 
• it can help academic institutions, 
and their staff, move to become 
“entrepreneurial actors,” by making 
innovation and entrepreneurship a core 
part of overall institutional strategy and 
by rewarding good innovation activities;
• an IP policy is also fundamental in 
helping institutions realise ethical and 
social commitments, align IP policy 
with their public sector mission and, 
especially, in ensuring the dissemination 
of knowledge through teaching and 
publications, research generation, and 
technology transfer so that research 
can contribute towards economic and 
social development. For these reasons, 
Lien Verbauwhede Koglin
Counsellor, IP Policies for Universities, World 
Intellectual Property Organization (WIPO)
The agenda for the modernisation of Europe’s 
higher education has made it a priority to 
reinforce the links between higher education, 
research and business to contribute to 
innovation (see Renewed EU Agenda for 
Higher Education). In this context, universities 
and research institutions often explore 
strategies that leverage their intellectual 
property (IP) assets and facilitate university-
industry partnerships. Doing so, however, 
requires thoughtful consideration of how this 
IP-based process best provides economic, 
environmental and social benefits for society 
at large – while also preserving the essential 
character of the non-profit educational and 
research institution. Institutional IP policies 
are the first step, and the foundation for 
achieving these goals. 
What is an institutional IP policy?
An institutional IP policy is a formally-adopted 
document which establishes the way an 
institution intends to deal with the ownership 
and disposition of its IP.  The main components 
of an IP policy include the following:
• rules on the ownership of the IP 
resulting from the institution’s own or 
collaborative R&D activities;
• obligations of stakeholders involved in 
the technology transfer process;
• rules of the institution on how to 
accurately identify, evaluate, protect and 
manage IP for its further development, 
usually through some form of 
commercialisation;  
• guidelines on the sharing of 
a comprehensive policy will serve the 
mission of the institution and strengthen 
its credibility and public image.  
What should institutions consider 
when drafting their IP policy?
The following good practices may be useful 
for developing an IP policy:
• Commitment at the highest level – 
University leadership is vital to make 
a modern IP policy a priority and make 
the goals and benefits clear to the entire 
academic community.
• Customisation – No “one-size-fits-all” 
policy can meet all the needs of any 
given institution. Each institution should 
shape its policy to reflect its approach to 
IP management and technology transfer, 
and to take into account the institution’s 
character, the nature of the technology 
itself, and the local “ecosystem”: the 
entrepreneurial conditions beyond the 
institution. 
• Redefinition of the institution’s mission 
as a source of problem-solving for 
the society – IP policies can accelerate 
innovation and university-industry 
collaboration and help deliver solutions 
to pressing social challenges. However, 
to support such a process, the mission 
of the academic institution needs to be 
redefined. That mission now extends 
beyond education and research to 
Institutional intellectual property policies – Getting the best out of academic research
An intellectual property (IP) policy 
is the cornerstone of innovation 
and creativity for universities and 
research institutions.  It provides 
structure, predictability, and a 
framework for talented researchers 
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solving key social challenges and helping 
stimulate economic growth.
• Focus on impact, not income – Instead 
of a narrow focus on IP as an income 
source, academic institutions should be 
engaged in providing solutions for the 
economy; the income stream will be 
greater and the benefits wider.
• Legal consistency – The provisions 
adopted in an IP policy should not 
contradict national or international laws 
and regulations. Institutions should have 
processes in place to ensure that their IP 
policy is in line with national legislation 
and is legally binding. 
• Incentives – Career structures for 
scientists in academic institutions 
have traditionally rewarded only 
academic accomplishments. IP policies 
should design incentives and redefine 
promotion criteria for faculty, to reward 
their active involvement in technology 
transfer activities. 
• Communication – While the policy 
development process is in itself a valuable 
undertaking, it is only the first step 
toward successful knowledge transfer, 
which also requires buy-in from senior 
management, reasonable expectations, 
and patience. The stakeholders of an 
IP policy (employees, students, visiting 
researchers, etc.) are normally not 
familiar with the complex issue of IP rights 
and transfer of technology. Therefore, an 
institutional IP policy should be short 
and comprehensive. Some institutions 
have found it useful to provide practical 
guidelines or a manual along with their IP 
policy, to explain IP management issues 
to their employees and students (such 
as best practices for students, guidelines 
for researchers, student handbook, 
etc.). Further, it is advisable that the IP 
policy be made available to the whole 
campus community through the hiring 
process, website, and other means of 
promulgation.
• Improvement and adaptation – An IP 
policy should be a living document and 
be subject to change by the institution.
How does WIPO assist?
The World Intellectual Property Organization 
(WIPO) provides capacity building programs 
and tools to support the development of 
IP Policies for Universities and Research 
Institutions. 
Available resources include a list of frequently 
asked questions; a database of real world 
IP policies, manuals, and agreements from 
over 70 countries; as well as a variety of 
free documents and practical guidelines. By 
April 2018, this webpage will also contain 
an IP Policy Template for Universities 
and Research Institutions, guidelines for 
customisation, a policy writer’s checklist and 
an IP commercialisation tool box. 
Would you like to add your institutional IP 











4The European IPR Helpdesk N°28, January - March 2018
Horizon2020 funding programme, for 
example, requires open access to the 
publications resulting from the projects they 
fund, at the latest six or twelve months after 
publication, depending on the discipline. The 
Wellcome Trust issues similar mandates, as 
do many national funders. The idea is that 
everyone should profit from research payed 
for by public money.
There are two prominent ways to make 
publications open access. Self-archiving, or 
the green road to open access, and open 
access publishing, the gold road to open 
access.
When your article has been published in a 
subscription journal, you can deposit an open 
access version in a repository, such as Zenodo 
or any repository at your disposal. Since many 
journals require the author to transfer his/
her copyright, the permission of the publisher 
is needed. Depending on the policy of the 
publisher, the version you deposit can be the 
preprint (the version before peer review), the 
author’s final peer-reviewed manuscript (the 
version after peer review without the layout 
Inge Van Nieuwerburgh 
Ghent University Library, OpenAIRE
Scholarly communication is at the core of 
research. Sharing the knowledge gained 
in a research project is a crucial part of 
the research cycle. Others can build on 
the outcome, collaborations emerge and 
expertise is acknowledged. Open access (OA) 
refers to the practice of making peer-reviewed 
scholarly research and literature freely 
available online to anyone interested. Open 
means that anyone can freely access, use, 
modify, and share for any purpose - subject, 
at most, to requirements that preserve 
provenance and openness. It does not affect 
authors’ freedom to choose where to publish, 
nor the right not to publish. It is a question of 
making knowledge available to your peers, to 
the professional in industry, the teacher, the 
interested citizen, and making information 
reusable by humans and machines. 
More and more funders require researchers 
to open up the research output of the projects 
they fund. The European Commission’s 
Science Set Free: Open Access to research output
of the publisher), or the publisher’s version 
(the published version). In some cases, an 
embargo period is required before the text 
can be made available in open access. You 
can check the publisher’s open access policy 
in Sherpa Romeo. This database indicates for 
Inge Van Nieuwerburgh 
Ghent University Library, OpenAIRE
www.openaire.eu
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many publishers which version you can self-
archive.
The second way is to publish scholarly works in 
an Open Access Journal. These journals don’t 
charge subscription fees. Published works 
are openly accessible as of day one. Typically 
open licences, such as the creative commons 
licences, will protect the publication. These 
licences indicate the level of reuse allowed. 
Can you reuse in a commercial environment 
or not, do you need to quote the source, do 
you have to share the re-used information in 
the same way the information was released? 
The licence regulates these issues as an 
upfront permission. 
Different publishing models support open 
access journals. Charging APCs (article 
processing charges) is a commonly used 
practice, but some are supported by a 
scholarly society, some use crowdfunding to 
cover the costs, and in some cases the library 
pays a membership fee. To find a qualitative 
open access journal, you can consult the 
Directory of Open Access Journals (DOAJ) to 
browse OA journals by subject. 
Bear in mind that many books follow the 
same path and can be found in repositories. 
Furthermore, the directory of open access 
books (doabooks.org) gives an overview of 
open access books.
No matter where you choose to publish, the 
green or the gold way, always remember to 
upload your publications to a repository. 
A repository handles exposure in search 
engines, is interoperable with other services 
through back-end APIs and is often quality-
controlled. In short, the repository increases 
your visibility. 
Moreover, a repository allows external 
infrastructures, such as OpenAIRE, to re-use 
the information and to build extra services. 
Let us look at OpenAIRE in more detail 
to show the advantages of Open Science 
infrastructures.
OpenAIRE is the European Commission’s 
initiative for an Open Access Infrastructure 
for Research in Europe, which supports 
open scholarly communication and open 
science on the one hand, and access to 
the research output of European funded 
projects on the other. As mentioned above, 
the European Commission implemented an 
open science policy in its funding programme 
Horizon2020. This policy includes a mandate 
for open access to publications and an (open) 
research data policy. OpenAIRE supports 
projects and researchers in complying with 
this policy.  The infrastructure gathers open 
access content from a network of institutional 
and disciplinary repositories around Europe 
and beyond. The portal gives access to 
both open access publications and EU-
funded scientific publications and datasets, 
registered in the 800+ participating data 
providers. OpenAIRE enriches the dataset as 
a whole and provides services such as direct 
reporting of publications in a project to the 
EC’s participant portal, monitoring tools for 
depositing, usage statistics and interchanging 
enriched data. Several other funders noticed 
the practical use of the infrastructure and 
decided to take part, e.g. Australian Research 
Council, Science Foundation Ireland, Deutsche 
Forschungsgemeinschaft DFG, National 
Science Foundation USA. 
OpenAIRE is however more than a technical 
infrastructure. The OpenAIRE community 
works to advance open science initiatives at 
national levels, through a network of National 
Open Access Desks (NOAD) in 34 countries. 
The NOADs follow up on local open science 
policy, connect the different stakeholders 
in their country and link them up globally, 
through OpenAIRE. What’s more, the network 
operates a European Helpdesk system for all 
matters concerning open science, including 
open access, data management, copyright 
and repository interoperability. Factsheets, 
guides, webinars and other helpful materials 
are developed. 
As open access stretches out to other parts 
of the research cycle, beyond publications, 
OpenAIRE is moving from a publication 
infrastructure to a more comprehensive 
infrastructure that covers all types of scholarly 
output. Cross-links from publications to other 
information are supported. It positions Open 
Access publications in the wider research 
context, i.e. through linking to funding 
information, associated datasets, software, 
and patents, and promoting and supporting 
good research data management practices. 
By doing so, OpenAIRE supports researchers 
to adhere to the FAIR principles, making 
research Findable, Accessible, Interoperable 
and Reusable.
It is clear that the future of research is open, 
and research can only be open.
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“Our advice to other researchers who want to secure investment is 
to contact their technology transfer office and consider protecting 
their IP.” 
In this issue we have interviewed Dr Dragan Indjin, Reader (Associate Professor) in Optoelectronics and 
Nanoscale Electronics at the School of Electronic and Electrical Engineering, University of Leeds, UK. He is also 
a COST Action Chair and Grant Holder with a success story that he is sharing with us.
INTERVIEW
Could you tell us about your current work in 
the field of laser devices and the importance 
of your research, in particular for end-users?
My primary research interests include 
infrared and terahertz lasers and detectors 
and their applications to imaging and 
sensing. Over more than two decades 
I have been working on understanding 
the quantum physics background and 
modelling of electronic structure and optical 
characteristics of specific semiconductor 
devices, so-called quantum-cascade lasers 
(QCLs). The ability to generate infrared 
or terahertz radiation with high power 
and high spectral purity, coupled with the 
compact nature of these laser devices, make 
them ideally suited not only to the study of 
fundamental science but also for real-life 
applications including gas-sensing, wireless 
communications, bio-medical imaging, 
security sensing and non-invasive inspection 
and atmospheric science.
At the School of Electronic and Electrical 
Engineering, University of Leeds, UK, we 
have established multidisciplinary routes 
to collaborate with partners and end-
users who are interested in using these 
laser devices, in particular in the terahertz 
frequency range. Terahertz QCLs have 
been designed, modelled, optimised and 
fabricated in-house in our institution. In 
addition, specific terahertz spectroscopic 
techniques, accompanied by sophisticate 
computer codes and integrated modelling 
software, have been developed and used for 
both understanding complex optoelectronic 
properties of devices and for their 
optimisation for particular applications.  
In your opinion what is the importance of IP 
in the research world?
Patenting is a way to document and protect 
research results for researchers. Having 
a patent application helps researchers to 
attract research funding from industries. 
Furthermore, having a granted patent 
also helps in evaluating and developing 
commercial opportunities arising from 
conducted research. It definitely helps in 
translating research into commercially viable 
outputs. That would be a key step to assist 
with exploitation through, for example, spin-
out companies, and to achieve maximum 
impact from research and eventually enhance 
public benefit.
Do you use IP to protect your research results 
and if so, have you faced any problem?
Yes, we do use patents to protect our 
research results. A recent good example is a 
sophisticated spectroscopic technique with 
quantum-cascade lasers we are developing in 
collaboration with researchers from the School 
of Information Technology and Electrical 
Engineering at the University of Queensland, 
Brisbane, Australia. The technique is called 
optical-feedback interferometry and in 
essence, employing self-mixing phenomenon 
allows a single QCL device to be employed 
as both a source of radiation and a coherent 
detector, which has enabled its wide 
application for materials analysis, three-
dimensional imaging, vibration-sensing and 
high-resolution microscopy.  
One of the most exciting prospective 
application is in terahertz bio-medical 
imaging, more specifically for the screening 
and early diagnosis of skin cancer. As an 
important outcome of this research, together 
with colleagues from Leeds Dr Paul Dean, 
Prof. Giles Davies and Prof. Edmund Linfield 
and from Brisbane, Prof. Aleksandar D. Rakic, 
Dr Karl Bertling, Dr Yah Leng Lim, Dr Thomas 
Taimre and Prof. Stephen Wilson, I am in the 
international patent application (PCT) process 
for  “a laser system for imaging and materials 
analysis”. We were lucky to have a strong 
support from the University of Queensland’s 
UniQuest commercialisation team and from 
the Commercialisation Service teams at the 
University of Leeds, who were – and still are – 
instrumental in this patent application.
A patent application is a very time consuming 
and expensive procedure. I would say 
cost is probably the most challenging 
problem we face, especially the cost of 
patent prosecutions in multiple countries. 
Another aspect of patent application is that 
researchers involved in the procedure should 
be “equipped” with patience and persistence 
and be ready for a very long process if they 
want their IP be protected across the globe. 
Therefore, apart from securing funding 
for international patent applications, they 
should be ready to deal with and reply to 
all comments raised by patent reviewers 
from different countries and try to defend all 
claims in their patent application. 
This is of the upmost importance! It is not 
enough having a patent application only in 
your own country; you should complete the 
full procedure internationally and defend 
all claims in the patent application if you 
want to have your IP rights fully protected 
and recognised. This is usually a much more 
complex and time-consuming process than, 
for example, the work typically done to 
publish research results in top international 
journals.
Do you think that IP protection of research 
results helps to obtain funding? What 
would you advise to other researchers who 
want to secure investment?
The IP protection of research results 
definitely helps to obtain funding from 
industry, for multiple reasons:
• The patent application allows us to 
clearly define the background IP that 
universities would bring into the project.
• Having a patent application shows 
to the industry partner that the 
universities intend to commercialise the 
collaboration outcome, which is what 
most industry partners want to see.  
• The patent application will give us a 
strong position when we negotiate for 
a licence agreement.
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Our advice to other researchers who want 
to secure investment is to contact their 
technology transfer office and consider 
protecting their IP. Industry partners like to 
see that there is an opportunity for them to 
obtain some competitive advantages for their 
business by having an option of exclusive 
access to the outcome of the research that 
they are funding. 
 
What has been the impact of the COST 
network that you have coordinated for the 
last 4 years? 
In my opinion, the COST research network 
has indeed been key to the collaboration 
I have developed over the past few years. 
Academic, clinical and small industrial 
partners from more than 25 European and 
COST associated countries have been part of 
the network, collaborating to substantially 
improve existing optical methods for skin 
cancer screening and early detection. In 
particular, recent results from our very 
successful collaboration with colleagues 
from the University of Queensland, that led 
to our above-mentioned joint patent for a 
laser imager and its prospective use in early 
skin cancer detection, was one of the key 
outcomes of this project.
The COST programme funds the networking 
activities that funded Actions organise, 
which is why the Action turned out to be 
a very efficient and useful mechanism. 
Not only did the Action help establish new 
- and strengthen existing - international 
collaborations between partners who already 
have core funding supported by national 
funding bodies, but it also provided young 
researchers with training opportunities, 
funded their short-term scientific exchanges 
and open access joint publications. 
The network planted a seed for further 
substantial joint grant applications between 
partners. In some sense, the COST Action was 
an ultimate source of funding, supporting 
collaboration between European and 
other overseas partners (for example from 
Australia).
What advice would you offer a European 
policy-maker to boost research and 
innovation? 
This is not easy to answer. In my opinion, a 
more substantial research funding is needed. 
Besides, the research community evidently 
desires an improved procedure for grant 
competition. Also, much better indicators 
and measures of success of already funded 
projects should be developed. Different 
stakeholders, prospective industrial or 
clinical partners and end-users should be 
better informed of scientific success and 
technological breakthrough achieved by 
particular research groups. Consequently, 
European funding sources and their reviewers 
who are evaluating new project applications 
should be aware of and support further 
development of successful stories. I am 
confident that open publications like your 
European IPR Helpdesk Bulletin would help 
to achieve these goals. 
Today, researchers at universities and 
academic institutions are investing huge 
amount of their time and energy to align their 
research ideas and achievements to research 
funding mechanisms and corresponding 
funding body administrations. Most often 
their academic careers and career progress 
in their institutions, especially in science and 
engineering disciplines, are directly related 
to their ability to attract research funding, I 
would say sometimes much more than their 
research abilities themselves. I think that 
policy-makers together should pay attention 
and help to find a balanced approach.
from the resources offered by peers or large 
companies, both to develop their own ideas, 
or to better navigate complex ecosystems. 
By collaborating, an SME can, for example, 
gain access to the technology of a large 
company and improve its own product or 
service, while the large company can benefit 
from the specific competence of the SME, 
complementing its knowledge and expertise 
Dr Claudia Tapia
4iPCouncil Chair and IPR Policy Director at 
Ericsson1
There are several good reasons why small 
and medium-sized enterprises (SMEs) choose 
to collaborate with other companies or with 
academia. For instance, SMEs can benefit 
Open Innovation – How to collaborate while keeping IP business protected
1 4iPCouncil represents leading inventors and innovators in Europe (SMEs as well as large companies) who believe that intellectual property 
 rights enable innovation and increase social and economic welfare. More information about 4iPCouncil is available at www.4ipcouncil.com.
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which case the parties may establish that the 
SME creator will give the result to the other 
party for free or sell it for a certain amount of 
money (e.g. a fixed price of EUR 10,000 per 
patent). It is also common that, in exchange, 
the large company (new owner) licenses such 
patent(s) to the SME-creator for free.
For jointly created IP results the scenario 
is much complex (“joint ownership”). For 
example, when parties decide to “co-patent” 
the results of the collaboration, i.e. both 
parties own the patent(s), the main challenge 
is to determine which law applies to such 
patent(s). The parties need to clarify the law to 
be applied regarding (1) the patent acquisition, 
(2) the scope of the rights conferred by the 
patent, and (3) the contractual agreements4. 
Negotiating how to deal with co-owned 
patents may be extremely time-consuming 
and lead to conflicting positions in the 
future5. What if the large company wishes 
to license its portfolio, including co-owned 
patents, but the SME refuses to license them? 
What if the university desires to license the 
patent to a competitor of the SME? What if 
one party decides to transfer its patent(s) to 
a third party and the other party disagrees 
with this transaction? Due to the multiple 
complexities that may arise during the 
negotiation and after the collaboration has 
been finalised6, parties often agree to split 
the patents, leading to sole ownership. Again, 
if the SME chooses not to pay for the filing 
and maintenance of the patent then, instead 
of splitting, a fixed price may be negotiated 
as a sell price per joint patent. In any case, 
the sole owner (large company or university) 
agrees in turn to give the SME a royalty-free 
licence for the patent(s) it acquired.
When collaborating with academia,  the SME 
may face the situation that the university 
wishes to publish the result as soon as 
possible. Therefore, it seems desirable that 
the SME introduces a clause in the agreement 
(e.g. an algorithm of an SME incorporated into 
a 5G antenna of a large company)2.
However, collaboration does not only imply 
opportunities but also risks. Therefore, it is 
essential that the SME learns how to protect 
the intellectual property (IP) and know-how 
that is created prior to, during or after the 
collaboration.
At the stage where the SME is exploring the 
opportunity to collaborate with someone 
external, it is advisable that both parties 
sign a non-disclosure agreement (NDA). The 
European IPR Helpdesk, for instance, provides 
a sample NDA. An NDA allows parties to share 
knowledge in general and safely disclose trade 
secrets. When the decision has been taken to 
collaborate, the next step is usually to sign a 
collaboration agreement. The goal is to make 
sure that there is a win-win situation, where 
parties agree not to block each other and 
there is a mutual understanding on IP-related 
issues.
Normally the agreement establishes that each 
party is entitled to access the IP and know-
how of the other party created (1) prior to 
(“background”), (2) outside (“sideground”) 
and (3) after the collaboration (For example, 
) and which is relevant to the “results”3 of the 
collaboration. 
However, this is usually limited to the IP and 
know-how needed for the party to use the 
results commercially. Background, sideground 
and postground can be licensed for free or 
under reasonable conditions, the later with or 
without monetary compensation.
IP that is created by one of the parties during 
the collaboration period (“results”) is typically 
owned by the party that creates it. A different 
scenario may occur if the other party, e.g. a 
large company or a university, has paid for the 
filing of the patents and/or the R&D efforts, in 
so that it has a period (30 days should be 
sufficient) to review the draft for publication 
and that the publication will only take place 
if jointly approved by the parties. Equally 
recommendable would be to agree that if the 
publication discloses the invention, there is a 
pause in the publication (e.g. 90 days) allowing 
the SME to file a patent prior to making the 
invention publicly available. Otherwise, the 
SME would lose the grant of a patent due to 
lack of novelty.
Collaboration is sometimes indispensable for 
an SME to compete successfully in a global 
market. By considering IP issues prior to and 
during the negotiation, an SME can obtain the 
best out of the collaboration.
2 Although this article focuses on SME collaboration with a large company or with a university, an SME can also participate in R&D consortia, 
 collaborate with public research institutions (not universities) and join an “open science” model, where IP is inexistent or licensed with little 
 or no limitations. See J.-N. Delage, IP issues in open innovation and collaboration, Building and Enforcing Intellectual Property Value, IAM, 
 2010, Pages 55-58. 
3 “Results”, as defined herein, are also referred to as “foreground”, which was the term used before the Horizon 2020 EU Framework Programme 
 for Research and Innovation.
4 Gorbatyuk et al. (2016) recommend parties to select the law applicable since the national laws in Europe establishing the rules to exploit co- 
 owned patents are not harmonised. 
5 Feldges and Kramer (2017) identify the following problems: (1) cost sharing (2) filing policy (3) exploitation and (4) licensing. See Robert P. 
 Merges and Lawrence A. Locke, Co-Ownership of Patents: A Comparative and Economic View, 72 J. Pat. & Trademark Off. Soc‘y 586 (1990).
6  As Gorbatyuk et al. (2016) explain, “collaboration parties tend to have conflicting business interests and different preferred legal regimes”.
The views expressed herein are the views 
of the author alone and do not necessarily 
represent the views of 4iPCouncil or 
Ericsson.
Dr Claudia Tapia 
4iPCouncil Chair and IPR Policy Director at 
Ericsson
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TECNALIA wins the European Innovation Award with its 
failure prediction system for Industry 4.0 developed with 
NEM Solutions.
TECNALIA Venture’s founder and CEO, Asier Rufino, talks about the award and the IP protection 
tools available in Europe.
INTERVIEW
What is A.U.R.A., your award-winning 
technology?
A.U.R.A. is a Big Data-based technology that 
helps in forecasting expected behaviour and 
identifying future failures in key corporate 
assets such as wind turbines or railway 
subsystems. This technology, industrialised 
and patented by NEM Solutions with 
TECNALIA’s cooperation during the research 
and development phase, is currently being 
applied worldwide in the wind power and 
railway sectors.
A.U.R.A. has conducted over 80 million hours 
of operation in over 65,000 assets connected 
worldwide. For example, 18,000 train wheels 
are supervised daily in the five continents.
In the wind power sector, it enables 
companies to plan predictive maintenance 
strategies while reducing operation 
and maintenance costs associated with 
unplanned downtime and increasing energy 
generation and wind turbine life cycle. With 
thousands of wind turbines supervised by 
A.U.R.A., there are many success stories 
where failure is detected often over one year 
in advance. The record of success stories in 
this sector confirms savings amounting to 
hundreds of thousands of Euros thanks to the 
identification of a single catastrophic failure 
at the right time. When this is multiplied 
by all the assets monitored, the outcome 
translates into millions in savings.
In the railway sector, this system improves 
passenger safety and security, guaranteeing 
greater punctuality in train services. Benefits 
go from the control of possible train wheel 
defects, to enhanced comfort as future 
failures in air conditioning equipment 
are detected. NEM Solutions clients have 
confirmed improvements of up to 35% in 
their budgets thanks to this technology 
and to NEM Solutions auxiliary services, 
increasing the useful life of assets by up to 
30%.
What does EARTO’s European Innovation 
Award mean for you?
The European Innovation Award was jointly 
granted to TECNALIA and NEM Solutions by 
EARTO, the highest European association 
in the field of innovation, for the “Impact 
Delivered” category, which rewards the best 
technology transfer practice. This is very 
important for us, because this is a recognition 
that connects to the core of our organisational 
mission, which is to “transform technology 
into GDP”. 
We are proud of seeing this technology, 
where TECNALIA has collaborated from the 
start, offering substantial profit and loss 
(P&L) impact to companies in the railway and 
wind power sectors, through NEM Solutions’ 
products and services.
Would you say European research companies 
are well positioned at a worldwide level?
Applied research organisations focused on 
developing and transferring technology to 
resolve P&L industry problems are a powerful 
tool for European companies’ competitiveness 
and, as a result, there is quality employment 
being created. There are parts of the 
developed world where applied research 
organisations don’t have the presence they do 
in Europe and this usually results in a smaller 
representation of industrial GDP out of overall 
GDP in these regions or countries.
I think top European RTOs benchmark well 
against other similar top organisations 
worldwide and, even more importantly, 
these RTOs contribute in a relevant manner 
to European companies sustaining their 
international competitive edge.
How can research come to commercial 
fruition?  
I like to point out that innovation is a very 
hands-on exercise that ultimately aims at 
getting the “cash register ringing”. For the 
cash register to ring out of a research project, 
you need several pieces to come into play:
Firstly, you have to make sure that you 
transform the research project into a 
technological product that resolves a problem 
that has a positive P&L impact on the end 
user companies (most of the research we do 
is targeted to B2B/B2G business models and 
in this setting it is almost axiomatic that you 
have to focus on resolving P&L problems). 
Secondly, you need to protect this 
technology in a way that will maximise its 
future economic value. 
Thirdly you need a well-rounded team made 
up of both technological profiles and also, 
critically, business/marketing/sales profiles 
that will bring the innovative products to the 
market. 
Last but not least, you need money (smart 
investors) brought by corporates, venture 
companies (VCs), family offices, etc. that 
will provide the “fuel” for the teams to have 
the time to sell the innovative products in 
the market and hence finally get the cash 
register ringing. 
Therefore, in strong innovation ecosystems 
around the world, you always find Minds – 
Management – Money type of stakeholders 
with critical mass, interacting to transform 
research into innovation. 
What should be improved and what can 
policy makers do to boost research and 
innovation?
I believe that policy makers, for instance 
at European level, are doing a good job at 
providing support in “isolation” to each 
of the three type of stakeholders: Minds 
(e.g. H2020 research budgets are very 
substantial); Management (e.g. there 
are also H2020 budgets for start-ups/
entrepreneurs) and Money (e.g. the EIB 
is the largest Limited Partner in Europe). 
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However, a more holistic view is missing in 
terms of fostering, perhaps even forcing 
the three type of stakeholders into working 
or interacting more often together. Often, 
rather than devising yet a new financial 
instrument to try to finance innovation, 
you could go further by trying to connect 
better: technological capabilities of RTOs/
universities (e.g. research financed by H2020 
programs, Minds) with SME Instrument 
Phase II beneficiaries (Management) and 
for instance the European Business Angel 
Network (EBAN, Money). 
 
What is your view on the IP protection tools 
available in Europe? 
Our experience is that EPO standards are 
very high and are both recognised and 
benchmark well internationally. We use the 
EPO quite systematically and as a result we 
have been in the top 6 organisations in Spain 
in terms of EPO filings for the last two years.
The Unitary Patent will reduce costs and 
complexity after EPO patents are granted. 
It was a bit cumbersome checking country 
by country in which ones you required 
protection, undergoing a very fragmented 
renewal fee system that required the use 
of representatives, etc. We think it is a clear 
improvement.
From your experience, is there any area 
where you see room for improvement 
in terms of IP management for research 
projects?
First of all, when it comes to IP, sometimes 
we tend to believe that IP serves to prevent 
someone from doing something that you 
are doing or want to do, but the most 
important fact is that IP ensures that you 
have legitimacy to do what you intend to do 
in order to pursue a business opportunity. In 
the context of patent infringement, litigation 
should come as a last resort solution after 
you try to explore in a creative way how you 
could articulate, for instance, a licensing 
that could be deployed instead of the capital 
to develop the product that the start-up 
requires.  
There is an iconic H2020 project in robotics 
(RoboTT-NET) that we are leading, where 
a group of top European RTOs have put in 
place a mechanism to identify early stage 
robotic s start-ups across different countries 
in Europe along with an instrument 
(technological voucher) to get RTO minds 
collaborating with these start-ups.
There is also a strong open innovation trend 
amongst large organisations, which have 
realised that perhaps some of the start-ups 
out there could be the seed of their future 
blockbuster products. In this context, we are 
also helping large corporate organisations 
reach out to start-ups through the means of 
venture building or acceleration incubation 
programs. 
Start-ups should be exploring these 
relationships with large corporate 
organisations while keeping in mind 
potential trade-offs in terms of future loss 
of control.
Finally, nowadays NEM Solutions turns 
digitalisation and advanced data analytic 
processes in the mobility and energy sectors 
into a unique revolutionary memorable 
experience. A.U.R.A., with its patented 
technology, offers a close collaborative 
environment for decision-making in the 
field of operation and maintenance. The 
chief aim of all this is helping their clients 




deal, cross selling or other type of commercial 
deals. 
Keeping this in mind is relevant, for instance, 
in the context of relationships inside European 
projects and consortia where IP is always a 
delicate matter. 
You have to clearly state what is the 
background you bring to the project, and 
specify the particular developments that will 
be inside your perimeter and thus susceptible 
of proprietary IP emanating from the project 
vs. shared IP. Then, if you commercialise 
something that originates from the project, 
the rights of first refusal of other consortia 
members, etc. come into place. It is quite 
cumbersome at the moment to develop and 
commercialise IP in the context of a European 
research project although these consortia 
could offer the opportunity to identify 
partners to commercialise IP.
As European innovation champions, what is 
your advice to start-up innovators?
As I mentioned before, Management and 
Minds must collaborate in a more systematic 
way as it occurs across the strong worldwide 
innovation ecosystems that spring to 
everybody´s minds (e.g. Israel; East-West 
Coast in the USA, etc.). We at TECNALIA/
TECNALIA Ventures foster this type of 
collaboration in a twofold way: firstly, launch 
and ongoing collaboration with spin-offs 
such as NEM Solutions. This SME gazelle is a 
clear example of the benefits of an ongoing 
collaboration with an RTO focused on both 
strengthening and improving the features of 
the existing products of the company and also 
bringing in new innovative products so as to 
keep the company’s competitive edge.  
Furthermore, in the context of our incubation 
accelerator program (Omega Zero to One), 
we try to find Management very early stage 
start-ups that are seeking capital to develop 
a technological innovative product and try to 
match it with the capabilities of our Minds 
TECNALIA is a benchmark research and technological development centre for Europe, with 1,400 experts of 30 different nationalities, 
focusing on transforming technology into GDP to improve people‘s quality of life, by creating business opportunities for companies. 
TECNALIA Ventures is a subsidiary of TECNALIA that was set up in 2013 and provides acceleration incubation and venture building services 
to TECNALIA’s most promising technologies - thus transforming these technologies into technology-based business opportunities that 
are commercialised either via new licences or via the launch of spin-offs. Furthermore, TECNALIA Ventures provides R&D valorisation 
services to a wide array of organisations ranging from government to universities, RTOs (Research and Technology Organisations), and 
companies or investors in Europe and South America.
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A win-win situation for both sides
In 2013, the FNR put in place specific funding 
instruments to encourage the translation 
of high-impact research into commercially 
viable innovations. Without an exploitation 
strategy, excellent research may “only” 
remain research work, never reaching its full 
potential and never creating an impact on our 
society. The FNR’s many initiatives range from 
pre-seed funding to kick-starting innovative 
projects, to facilitating symbiotic partnerships 
between researchers, businesses and 
ecosystem members2. 
Such collaborations are a win-win for both 
sides: businesses gain access to creative 
minds, while researchers get the chance to 
take their research to the next level and have 
a socio-economic impact. 
As it is the rationale of a research institution 
to generate, develop, exploit and diffuse 
knowledge and technological assets3, 
collaborations with SMEs just seem obvious. 
Exploitation of research results helps to 
accelerate scientific progress as companies’ 
feedback flows back into research.  Knowledge 
and technology transfer to existing or 
newly created companies open a channel 
of innovation between the RPOs and the 
private sector. This knowledge transfer is also 
an important open innovation vehicle that 
can contribute to the competitiveness of the 
company in a global challenge and excellent 
talent attraction.
On a broader level, one can say that 
exploitation of research results may support 
the economic development of a country, 
preserve its competitiveness and probably 
contribute to attracting foreign companies. 
Dr Andreea Monnat
Head of Unit – Innovation Programmes, 
The Luxembourg National Research Fund
Private R&D is doing very well, but only 
if one is talking about hugely prosperous 
companies - like for example the tech world’s 
GAFA (Google, Apple, Facebook, Amazon), 
etc. Unfortunately, few small and mid-sized 
enterprises (SMEs) have the resources to 
invest in or pursue early-stage innovation. 
This is where R&D collaborations with public 
research institutes could play a pivotal role. 
Companies and research institutes are two 
partners that might seem distant at first 
sight, but who are actually two sides of the 
same coin. In Luxembourg, the Luxembourg 
National Research Fund (FNR)1 aims to bring 
these parties together, as it is convinced 
that public-private partnerships, and thus 
the exploitation of research results, enhance 
and underpin enterprise competitiveness and 
societal development. 
Since its foundation in 1999, the FNR 
focuses on building a sustainable research 
environment, from the ground up, with 
infrastructure and opportunities that are 
attractive for the brightest minds. Over the 
past two decades, the FNR has invested 
large amounts of money into both high-
quality scientific projects and outstanding 
professionals and has established itself as 
the guarantor of “excellence” in its funded 
research. After this development phase, that 
lasted some fifteen years, the Luxembourgish 
research ecosystem entered the phase of 
consolidation. For the FNR, this meant the 
time had come for harvesting the fruits of its 
investments. This is why the funding agency 
diversified its strategy in recent years and 
now also contributes with funding to support 
innovative, applied research in collaboration 
projects between companies and research 
performing organisations (RPO).
In Luxembourg, public-private partnerships, 
in areas that demonstrably enhance and 
underpin enterprise competitiveness and 
societal development in the country, are 
supported by the FNR. 
The FNRs industry partnership 
programmes
For collaborative research (between a 
company and a research institute), two types 
of funding exist. On the one hand, there 
is a funding possibility via the Ministry of 
Economy through the research development 
and innovation law. And on the other hand, 
a competitive funding via the FNR. The latter 
has three funding schemes that finance either 
PhDs and Postdocs, or research projects in 
companies. 
The “Industrial Fellowships” programme 
supports researchers who carry out their 
PhD or postdoc training in collaboration 
with a company in Luxembourg. The 
“IPBG” (Industrial Partnership Block Grant) 
programme awards a block of PhD and/or 
postdoc grants in which Luxembourg-based 
industry partner(s) active in R&D take the lead 
in arranging a research programme with a 
Luxembourg-based public research institution 
of their choice. The “Bridges” programme 
supports applied research that meets the 
needs of industrial partners. 
The FNR’s future challenges will lie in 
developing strategic partnerships and putting 
standard, functioning frameworks in place 
with institutions, politicians, media, the 
society, researchers and the government. Only 
by working together with the same goals in 
mind we can have a greater impact on society 
and on the Luxembourgish economy. The FNR 
should become a place where researchers feel 
free, protected and where their efforts are 
appreciated in the process of generating ideas 
that will positively change the world.
R&D is vital to the process of innovation – How research leads to innovation and why 
companies should seek collaboration with research institutes.
1 The Luxembourg National Research Fund is the main funder of research activities in Luxembourg and invests public funds and private donations 
 into research projects in various branches of science and the humanities, with an emphasis on selected core strategic areas.
2 https://www.fnr.lu/innovation-industry-partnership.
3  Successful collaborations between companies and research institutes – Guide issued by Luxinnovation, with the support of IPIL G.I.E., FNR and 
 the Ministry of Economy.
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“It is important to protect the results obtained from research projects 
and prove their ownership. This can allow the results to be disclosed 
without the threat of them being used by others.” 
Professor Jennifer Littlechild has coordinated and participated in several transnational EU and ERA-NET 
projects and is currently participating in a project which is funded within ERA CoBioTech.
INTERVIEW
Could you briefly tell us what is ERA-NET 
and your experience coordinating research 
projects?
The ERA-NET is a funding scheme that 
allows small consortia to work together from 
different EU countries on a specific project 
of interest to the call, in my case Industrial 
Biotechnology. 
The grant is evaluated by the ERA-NET using 
independent experts in the scientific area. 
It is a two-stage process and the applicants 
are allowed to comment on the referee’s 
comments if selected for the second round. 
One partner is the lead on the project and 
is involved with the overall management 
together with other partners. The funding 
is provided from the individual countries’ 
funding streams which were part of the 
original grant concept. The ERA-NET scheme 
has advantages in that the funded projects 
help to access further funding from member 
countries for Industrial Biotechnology. 
The complementary expertise of different 
partners allows the development of 
multidisciplinary projects which could not be 
addressed by one partner alone.
The funding available and the participation 
of different countries can vary from call to 
call. This can be frustrating for applicants as 
to whether they will be able to participate 
or not. There is also variation in the funding 
levels available in different countries which 
can create an imbalance in the overall 
project financing, although participants can 
be partners in the grant using their own 
alternative funds if available. In my case, 
I have helped to write an ERA-NET grant 
application in a round where the UK funding 
agency did not offer support. I was able to 
still be involved in this ERA-NET project as a 
sub-contractor and able to participate in the 
management committee. 
The ERA-NET projects have a positive 
contribution in helping to establish consortia 
which can later be involved in larger Horizon 
2020 consortium grant applications which 
are totally funded by the EU. The new call 
for ERA-CoBioTech is good since it covers a 
wider remit including both Synthetic Biology 
and Systems Biology together with Industrial 
Biotechnology. I am a partner in a consortium 
participating in a project called HotSolute, 
that has been funded in the first call for this 
programme.
My experience in co-ordinating an ERA-NET 
project is with the grant THERMOGENE. This 
project aimed to use nature’s diversity to 
find new thermophilic transfer enzymes that 
have commercial applications in Industrial 
Biocatalysis for the production of optically 
pure intermediates for the pharmaceutical and 
agrochemical industries. These enzymes need 
to be robust for such industrial applications 
and need to have the correct substrate and 
stereospecificity for the commercial process. 
The use of biocatalysis opens the way for a 
range of green and sustainable processes for 
chemical synthesis that produce less toxic 
waste and result in purer compounds with 
one chirality offering improved and safer 
drugs.
The achievements of the THERMOGENE 
project have been that many new 
thermophilic transfer enzymes have been 
identified, cloned, purified and characterised 
from all of the four different enzyme types 
(transaminases, transketolases, prenyl 
transferases and hydroxymethyl transferases). 
The robust nature of these enzymes to both 
temperature and organic solvents makes 
them interesting candidates for new industrial 
applications.
Sharing of research facilities within the 
consortium and exchange of protein samples 
and expertise has contributed to the success 
of the project. 
Apart from the scientific benefits of the ERA-
NET project described above, good personal 
contacts were made between partners, 
postdoctoral fellows and students associated 
with the THERMOGENE project who have 
experienced meeting in the countries of 
different partners.
As a researcher and coordinator, do you 
think IP is important for your work?
As a researcher and coordinator, IP is certainly 
important to consider. It is important to 
protect the results obtained from research 
projects and prove their ownership. This 
can allow the results to be disclosed without 
the threat of them being used by others. 
This sometimes can be in conflict with the 
pressures of the academic community to 
publish their results in open access journals. 
For projects such as THERMOGENE it is 
not usually possible to patent an individual 
enzyme, but one can patent the process 
which the enzyme is used for. In this sense 
it is important for the project to gain advice 
from an industrial end-user as to which are 
the “highest priority” enzymes required to 
produce the most important industrially 
relevant chemical intermediates. It is 
important to have this industrial link with 
the ERA-net project, whether as an advisor 
to the grant team or a full industrial partner.
Before entering into a research project, do 
you put in place any IP measure?
Before starting the project, a consortium 
agreement covering any IP issues was 
put in place between all partners of the 
THERMOGENE project, which was agreed 
with Exeter University (the co-ordinating 
UK partner) and signed by all partners. The 
use of background IP should be considered 
and should be declared in the consortium 
agreement before the start of the project. 
In our case, the background IP that each 
member was going to bring to the project 
was clearly defined in the agreement and 
access rights to that IP by each member (in 
order to perform their own activities within 
the project) were decided on a royalty-
free and non-exclusive basis. Furthermore, 
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it was agreed that the parties would be 
granted access to that IP under fair terms, 
if needed for their own internal commercial 
use, provided they requested such access in 
writing. It is important that all consortium 
partners are represented on a management 
committee to address IP issues.
How do you manage the ownership of IP 
related to research results? 
The consortium agreement should address 
the issues of ownership of IP related to the 
research results of the project. In the case 
of the THERMOGENE project, the issues of 
the ownership and protection of the results 
were addressed. It was agreed that the 
results obtained should be the property of 
the party who generated them. That party 
has to ensure that the ownership, title and 
all the IPRs in any results generated by its 
staff or subcontractors are transferred or 
assigned to it. 
Joint ownership of results should also be 
foreseen in the agreement. We agreed that 
the shares of ownership should reflect the 
contribution of each joint owner as accurate 
as possible, and that they had to agree 
separately on the management of the joint 
ownership. The disclosure of the foreground 
IP should be discussed with all partners 
involved in the consortium before any action 
of individual partners.
How challenging is it to engage investors in 
research projects and, what role do IPRs play 
in this process (e.g. holding a patent may 
help to get fund)?
It is anticipated that an SME will be 
established to produce some of the enzymes 
developed from this project and make them 
available in kit form to interested companies. 
The THERMOGENE enzymes are not currently 
available to industry. It is always a challenge to 
engage initial investors in such an enterprise.
The available time on a 3 year ERA-net 
project which has to identify new enzymes 
and characterise them is not enough to put 
in place patents for their applications in 
specific industrial processes. It would be good 
to have a follow on fund to try to exploit the 
thermostable enzymes. This would however 
ideally have to be provided centrally from 
EU funds. This would then help to engage 
potential investors to carry out further 
research to allow commercial application. 
There are follow on funds for exploitation 
of BBSRC funded projects in the UK. These 
consist of relatively small amounts of funding 
to enable preliminary commercial activities. 
In your opinion, is there anything that 
should be improved regarding available IP 
protection tools in the field of research and 
development?
It is sometimes difficult when only 
universities and research institutes are 
involved in a project to secure the funding 
to support and more importantly maintain 
potential patent applications. Funds to assist 
in this would be helpful.
The European IPR Helpdesk Helpline answers 
your questions concerning intellectual 
property (IP) within three working days. You 
get practical, and free-of-charge, first-line 
support directly from our IP experts.
If you are curious about the type of IP queries 
that the Helpline has recently been dealing 
with, these are shown in this illustration.
If you would like to talk to one of the 
IP experts of our Helpline, please dial 
+352 - 25 22 33 – 333
www.iprhelpdesk.eu/helpline
Your IPR Queries Matter to 
Us: Ask the Helpline
EU SMEs involved in 
transnational activities 
IP in EU-funded projects
I am specifically interested in guidance around the introduction of Background IP - how it is declared in the Consortium Agreement.
We wonder how we can protect the idea for commercial use.
What should we do to best protect IP? Is it possible to add a subcontractor as a party to the Consortium Agreement? Would it give more protection than Non-Disclosure Agreements signed with the beneficiaries that will provide confidential data?
Do you have any publication or example concerning the application of NAGOYA Protocol for the IP of a natural microorganism?
I’d like to understand what is the procedure to register and protect, concerning copyrights, a software app.
I have been receiving aggressive e-mails from a company in China threatening with overtaking my brand in China and worldwide if I do not pay. What shall I do?
Is it possible for the partners that need access to this excluded IP to request access? Or should the owners of the IP reverse the exclusion?
We are interested in licensing one of our discoveries that has been researched as part of a number of ERC grants. Would like to know how to go about receiving permission from the ERC to license the IP.
14
The European IPR Helpdesk N°28, January - March 2018
FREQUENTLY ASKED QUESTIONS
IP RIGHTS IN  GENERAL:
I have a question regarding a publication 
I participated on by providing some 
drawings. The authors did not include me 
in the authors‘ section but simply cited 
me in acknowledgments. They consider 
that, as I have not provided any scientific 
contribution to the publication, I am not an 
author. What do you think about this case?
Writing is not always seen as the only 
criterion for being accepted as a co-
author. Depending on the field of research, 
collecting, processing, or analysing data, 
performing practical experiments, or 
simply being part of a project, can also 
be considered as co-authorship. There 
exists no universal standard for authorship 
assessment. Many research institutions 
have developed their own ethical guidelines 
that regulate co-authorship. Nevertheless, 
there is one rule that is always present, 
and which seems to be of paramount 
importance for the determination of the 
authorship: authors should be those who 
have contributed substantially to the work 
(for the most part, essentially). We could see 
that you have created several graphics that, 
in our opinion, merely complement the main 
content of the article. We have our doubts 
if such contribution can be considered as 
“substantial” in this case. It is, at the same 
time, a good practice to mention all the 
contributors in the acknowledgements 
– which has been done in this article. 
Additionally, you could ask the authors to 
put your copyright notice under each of 
your graphics. In order to avoid this kind of 
unclear situations in the future, we suggest 
that you discuss this kind of issue before you 
decide to contribute to a scientific work. As 
mentioned, assessment of the authorship 
has no strict rules, and the distribution of 
authorship can be agreed upon between the 
collaborating participants before the work 
starts. It is also a common procedure to 
conclude a written agreement between the 
collaborators.
EU-FUNDED PROJECT:
Exergy is coordinating one of the 
Horizon 2020 projects named EcoBulk. 
Just recently, we have established an 
external collaboration with a company 
that specialises in the recycling of waste 
materials from wind turbine blades. This 
company will not formally join the EcoBulk 
consortium, instead we have agreed 
on a certain scope of work that will be 
undertaken by some partners of the EcoBulk 
consortium and this external company for 
mutual benefit. We are at the stage where 
we would like to formalise this collaboration 
with some kind of agreement to make sure 
that the expectations and tasks of each party 
are clear from the beginning.
Could you provide us with some advice on 
this?
We understand that you are looking for a 
template of a subcontracting agreement that 
would be suitable for Horizon 2020 projects. 
Unfortunately, to the best of our knowledge, 
no such template exists – the European 
Commission has not released any official 
document for this purpose. A reason for that 
may be that the contents of such agreements 
can vary greatly in scope, depending on the 
complexity of the work subcontracted, on 
the expected compensations, and on the 
expectations of both parties regarding e.g. 
IPR. All of these parameters have to be defined 
contractually: there is no rule and therefore 
templates will never fit all situations. Drafting 
an efficient subcontracting agreement may 
be a complex matter and should be entrusted 
to a commercial lawyer, in order to avoid any 
pitfalls and ensure that both parties’ interests 
are secured (in particular regarding warranties 
and liability). Nonetheless, your agreement 
could cover the following points: 
• Identification of the parties 
• Definitions 
• Purpose of the agreement: 
subcontracting agreement signed in the 
context of project X regarding Y 
• Obligation of the parties: precise 
description of the tasks entrusted to the 
subcontractor, and relevant milestones 
or timeframe; the beneficiary may also 
have some obligations (e.g. to provide 
specific input or guidance) 
• Price and payment terms for the work 
that will be performed, and relevant 
milestones or timeframe 
• If relevant, monitoring mechanisms 
(e.g. checking that the work is correctly 
performed before each payment 
instalment is carried out) 
• Ownership of the work and related 
intellectual property rights: this part 
should mention which party (beneficiary 
or subcontractor) retains the IPR over 
the subcontracted work. In principle, the 
beneficiary should acquire ownership of 
the results and related IPR developed 
under the subcontracting agreement, 
or at least appropriate user rights (see 
further explanations below) 
• Confidentiality clause 
• Liability and warranties clause - relates 
to the liability of either party to the 
other for breach of the obligations 
under the agreement 
• Duration of the agreement - the 
agreement should include provisions 
on the date when it enters into 
force, its duration and the forms of 
termination 
• Law and jurisdiction clause 
• Signatures and date 
Regarding intellectual property rights, 
please keep in mind that in Horizon 2020, 
subcontractors are third parties to the 
grant agreement, and as such have no 
specific, automatic ownership rights to 
the results. Therefore the involvement 
of subcontractors in a project should not 
hinder the implementation of this project, 
and any rights that they require should not 
deprive project partners of the possibility 
of fulfilling their obligations under the 
project: performing their tasks, granting 
access rights, disseminating their results, 
exploiting them, and so forth. 
For this reason, the Horizon 2020 Rules for 
Participation (RfP) provide that “if […] any 
party working for a participant [is] entitled 
to claim rights to results, the participant 
concerned shall ensure that it is possible 
for those rights to be exercised in a manner 
compatible with its obligations” (see 
article 41.3 RfP). That is why it is generally 
recommended that project beneficiaries 
which resort to subcontractors make it 
clear, in the subcontracting agreement, that 
the ownership vests in the beneficiary and 
not the subcontractor. This is usually the 
most straightforward solution. 
If the subcontractor insists on getting 
ownership of the work performed, the 
project partner would at least need to 
negotiate all appropriate licensing rights 
in order to be able to access and use the 
results in the same way as if it owned 
them. In that case, the terms of the licence 
should be sufficiently broad to allow the 
beneficiary to perform all its obligations 
under the grant agreement – during project 
implementation and the exploitation phase 
alike. Do not hesitate to contact us again 
should you need more clarifications on this 
particular point.
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The European IPR Helpdesk on tour: Take a look at a selection of our recent events
In the last three months the European IPR Helpdesk Team participated in a number of IP events all over Europe, and provided several IP workshops 
building capacities in IP management among SMEs and researchers. 
10th Forum for Innovation 2017  
Bucharest/Romania
25 -27 October 2017
Meet us at these upcoming conferences
• 5-9 March 2018: all over Europe 
Start-Up Week Europe 
Upcoming IP training events
• 25 January 2018: Vilnius, Latvia  
VILNIUS! IPforBusiness Training
• 07 February 2018: Brussels, Belgium 
IP&Coffee: on-site training session: IP 
Commercialisation and Licensing
• 26 February 2018: Riga, Latvia 
RIGA! IPforBusiness Training
• 14 March 2018: Rome, Italy 
ROME! IPforBusiness Training
• 21 March 2018: Brussels, Belgium 
IP&Coffee: on-site training session: 
Technology Transfer 
• 11 April 2018: Brussels, Belgium 
IP&Coffee: on-site training session: IP in 
EU funded projects
Upcoming webinars
• 07 February 2018 
IP Commercialisation and Licensing
For further information, please have a 
look at our online event calendar.
• 28 February 2018 
Geographical Indications 
• 21 March 2018 
Technology Transfer 
• 11 April 2018 
IP in EU funded projects
ICT Proposers Day 2017 Budapest/Hungary 9 -10 November 2017
Biotech Research & Innovation HackBrussels/Belgium 06 December 2017 
The Autumn Meeting for the European IPR 
Helpdesk Ambassadors was held in Brussels 
on 19-20 October 2017. On the first day of the 
event, the agenda focused on which further 
services and tools can be developed for the 
benefit of SMEs, and how the Helpdesk and 
Enterprise Europe Network (EEN) services can 
be better integrated. 
On the second day of the event, the 
Ambassadors welcomed the event’s 
keynote, Ms Barbara Weizsäcker, Secretary 
General of the European Exhibition 
Industry Alliance (EEIA), who delivered a 
stimulating presentation on handling IP in 
internationalisation activities, trade fairs and 
B2B events. 
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To conclude this learning experience, why not strengthen your knowledge of IP and research with this 
multiple choice test? Only one answer is correct for each question: try to find them!
1. According to WIPO, what is an institutional IP policy?
(a)  A formally-adopted document which establishes the access rights regime of the parties participating in a project. 
(b)  A formally-adopted document which establishes the way an institution intends to deal with the ownership and disposition 
 of its IP.
(c)  A formally-adopted document which describes the IP owned by an institution. 
2. According to OpenAIRE, what is open access?
(a)  The practice of providing access rights to the IP owned by academic and research institutions under fair and reasonable 
 conditions. 
(b)  The practice of making peer-reviewed scholarly research and literature available online to third parties, under payment or 
 free of charge, depending on the conditions applicable.
(c)  The practice of making peer-reviewed scholarly research and literature freely available online to anyone interested.
3. Dr Dragan Indjin, from University of Leeds, explains that IP protection of research results helps universities to obtain funding from 
industry because:
(a)  Industry partners are not interested in unprotected research results.
(b)  IP protection contributes to background definition; it shows industry partners the university’s intention to commercialise the 
 results; it gives universities negotiation power. 
(c)  Industry partners do not have the time and the financial means to evaluate whether the results generated by universities are 
 protectable. 
4. According to Claudia Tapia, from 4iPCouncil, what is the main challenge when parties decide to “co-patent” the results of a 
collaboration?
(a)  The main challenge when “co-patenting” is to determine the jurisdiction applicable in case there is a conflict regarding the 
 patent. 
(b)  The main challenge when “co-patenting” is to determine the responsibilities of the parties regarding the patent protection 
 costs. 
(c)  Neither of the above is correct.
5. According to Asier Rufino, from Tecnalia, what can policy makers do to boost research and innovation?
(a)  Reform the patent system, which is obsolete
(b)  Create new financial instruments to finance innovation. 
(c)  Force stakeholders into working or interacting together more often.
6. According to Dr Andreea Monnat, from the Fonds National de la Recherche Luxembourg (FNR):
(a)  Only big companies, such as Google or Apple, have any chance to do well in R&D. 
(b)  The FNR advocates public-private partnerships. 
(c)  Neither of the above is correct. 
7. According to Professor Littlechild, coordinator of the ERA-net project THERMOGENE:
(a)  The academic community is always in favour of early publication of their results in open access journals and against IP 
 exploitation. 
(b)  The definition of background is an important IP measure to implement before entering into a research project. 
(c)  The parties to the ERA-net THERMOGENE project agreed on a joint ownership regime where the results would be commonly 
 owned, irrespective of which party generated them. 
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PATENT QUIZ
Fancy a Little Quiz? 
As you know, in every issue we include a patent quiz to help you develop your patent searching skills using Espacenet. Why don’t you try using 
Espacenet today? Here comes our new quiz:
SOLUTION IP AND INNOVATION QUIZ
Letter Soup
To conclude this learning experience, why not 
strengthening your knowledge on IP and innovation 
with this letter soup? The concepts in bold capital 
letters below are hiding in this chaotic soup, try to 
find them!
1. TRADE SECRETS and PATENTS are likely to be 
used in companies with internal R&D, with 
high innovation expenditure or when the 
innovation is new to the market.
2. The effective use of IP TOOLS plays an 
important role in reducing risk for players 
involved in the success of INNOVATION in the 
market.
3. TRADE MARKS and industrial DESIGNS play an 
important role in the marketing process.
4. The breeder’s exemption has always been relied 
upon by breeders for further improvement to 
each other’s PLANT VARIETIES and to foster 
innovation in plant BREEDING.
5. Patents help SMEs to attract investors 
and support their image to consumers as 
companies offering high-quality products.
S E I T E I R A V T N A L P T
Y B I M R I N P R O P J X U G
G H S Y F A P A I F X B F N M
M B G Q L B D T S C W A I P K
E M A V B E A E O T Z D Y A S
C J Q U M V M N S O E F F M Q
G I B A O Y G T W E L B E E E
O U R N X F T S R Q C S L S C
E K N F L H N B A T S R Y S X
S I E D T G D M P L E L E S E
Y K L R I R P O B J I I I T H
S A B S Z F C K J C N F D J S
A P E K V G L N I J R K J P D
R D Z T E N T S L K G V Q L L
W Z L Q R Y Y P A H T R J R J
Not at home, no problem. 
One major disadvantage of ordering online 
for later delivery is that you have to be at 
home to accept the package. Imagine a 
locker system close to your place to which 
you can have your package delivered and 
where you can pick it up later.
Using ESPACENET, try finding patents 
covering this concept and its improvement.
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SOLUTION PREVIOUS PATENT QUIZ
Step one: This quiz requires you to find the 
oldest patent that can be characterised 
by combining the airplane concept with 
electric. The concept airplane is best 
covered by a broad classification symbol 
covering airplanes in a very generic manner. 
This can be done by a classification search 
looking for airplane. B64C is the best 
symbol that can be used to broadly cover 
aeroplanes.
The simple combination B64C electric* 
yields thousands of results. It would be 
quite difficult to find the oldest one from 
this set of documents. A better way is to use 
the date range search feature in ESPACENET: 
0000:1930 entered as a publication date 
in the search screen retrieves all patents 
published up to 1930.
Combined with the first search statement, 
you obtain this list of patents.  
This list can be sorted by the date of 
publication in ascending order. 
You will then be able to retrieve the 
following patents:
GB191113492 (A)  -  Improvements in the 
Transmission of Electric Power.
From 6 June 1912
GB105948 (A)  -  Improvements in and relating 
to Flying Machines.
From 30 April 1917
US1511448 (A)  -  Electrically-propelled 
aircraft
 From 14 October 1924 
The patent dated 1912 seems to be the 
oldest one. One can try finding even older 
ones using the full-text search feature in 
ESPACENET.
Using this feature, you will find this French 
patent by looking for electric* in the 
complete description of patents that have 
been digitised. 
FR375273 (A)  -  Aéroplane automoteur
From 4 July 1907
Our readers can look further and try to find 
an even older patent than this one.
Fly electric
The Age of Flight has an extraordinary 
carbon footprint. Consider that when you 
fly round-trip from New York to Paris, that 
travel generates approximately the same 
greenhouse gas emissions as heating a 
residential home for a year.
Why only drive electric when you can 
also fly electric. Major players like Airbus 
are working on such aircrafts. This field 
is of course patented. The challenge this 
time is to find the oldest possible patent 
covering this invention: the electric aircraft. 
Using ESPACENET, try finding some old if not 
the oldest patents covering such aircrafts.
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GLOSSARY
Institutional IP policy is a formally-adopted document which establishes the way an 
institution intends to deal with the ownership and disposition of its IP.  
Open access (OA) refers to the practice of making peer-reviewed scholarly research and 
literature freely available online to anyone interested.
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